Abstract
Clinical Trial Accrual: Obstacles and Opportunities.
Highlights
Cedars-Sinai Medical Center, Los Angeles, CA, USA Keywords: clinical trial accrual, gynecologic oncology, accrual, participation, enrollment
Clinical trials, defined by the National Institute of Health as “a research study in which one or more human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes” [2], are the primary focus for enrollment of most patients with an active malignancy
A panel of experts convened by the NCI and ASCO to discuss barriers to clinical trial enrollment in 2013 [4] cited barriers in three areas as most significant: [1] patient/community, [2] physician/provider level, and [3] site/organizational
Summary
Cedars-Sinai Medical Center, Los Angeles, CA, USA Keywords: clinical trial accrual, gynecologic oncology, accrual, participation, enrollment. Less than 2% of patients diagnosed with cancer participate in a clinical trial in the United States [1]. Gynecologic oncology patients do not appear to participate in trials with any more frequently than other cancer types.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call